Talia Eisenberg is the co-founder of Beond Ibogaine, a leading treatment and research center in Mexico specializing in ibogaine-assisted care for trauma, addiction, PTSD, and personal optimization. After overcoming opioid addiction through ibogaine herself, Talia set out to build a safe, ethical, and clinically advanced environment for transformation. That journey now shapes Beond’s mission: making evidence-based psychedelic therapy accessible to those in crisis and to anyone seeking clarity, renewal, and growth. With an MBA in sustainability and a background in values-driven entrepreneurship, Talia guides Beond’s clinical, research, and strategic direction. She has become a key voice in advancing ibogaine’s place within the national conversation on drug policy, working alongside researchers, advocates, and policymakers to move the substance toward broader legitimacy and access. Her advocacy also spans women’s health and trauma recovery. As a speaker, Talia challenges outdated models of addiction and healing, redefining what’s possible at the intersection of science, policy, and personal transformation.